Vertebral compression fractures in multiple myeloma .2. Assessment of fracture risk with MR imaging of spinal bone marrow

被引:54
作者
Lecouvet, FE
Malghem, J
Michaux, L
Michaux, JL
Lehmann, F
Maldague, BE
Jamart, J
Ferrant, A
VandeBerg, BC
机构
[1] UNIV CATHOLIQUE LOUVAIN, ST LUC UNIV HOSP,DEPT HEMATOL, B-1200 BRUSSELS, BELGIUM
[2] MONT GODINNE UNIV HOSP, CTR BIOSTAT & MED DOCUMENTAT, YVOIR, BELGIUM
关键词
bone marrow; abnormalities; gadolinium; myeloma; osteoporosis; spine; fractures; MR;
D O I
10.1148/radiology.204.1.9205247
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine the utility of bone marrow magnetic resonance (MR) imaging in the assessment of risk of vertebral compression fractures in patients with multiple myeloma. MATERIALS AND METHODS: In 50 patients with stage III multiple myeloma, 280 MR examinations of the thoracolumbar spine obtained at diagnosis and during treatment (mean follow-up, 28 months) were analyzed to determine MR patterns of bone marrow involvement before treatment and the occurrence of vertebral compression fracture at follow-up. Four MR patterns of marrow involvement were determined: A, normal marrow appearance; B, fewer than 10 focal lesions; C, more than 10 focal lesions; and D, diffuse infiltration. Fracture-free survival was compared according to these patterns. RESULTS: During follow-up, 131 vertebral compression fractures appeared in 37 patients. Patients with pattern A (n = 10) or B (n = 16) had significantly longer fracture-free survival before occurrence of the first, second, and third fractures than those with pattern C or D (P < 10(-5)). Relative risks of first, second, and third fracture occurrence for patients with pattern C or D compared with those with pattern A or B were 6.2, 9.1, and 11.0, respectively. CONCLUSION: Determination of MR patterns of spinal bone marrow involvement is a potential relevant factor to predict the risk of vertebral fractures in patients with stage III multiple myeloma.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 32 条
  • [1] IMPORTANCE OF QUANTITATIVE HISTOLOGY OF BONE CHANGES IN MONOCLONAL GAMMOPATHY
    BATAILLE, R
    CHAPPARD, D
    ALEXANDRE, C
    DESSAUW, P
    SANY, J
    [J]. BRITISH JOURNAL OF CANCER, 1986, 53 (06) : 805 - 810
  • [2] BATAILLE R, 1990, CANCER-AM CANCER SOC, V66, P167, DOI 10.1002/1097-0142(19900701)66:1<167::AID-CNCR2820660130>3.0.CO
  • [3] 2-9
  • [4] Management of myeloma with bisphosphonates
    Bataille, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 529 - 530
  • [5] EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA
    BELCH, AR
    BERGSAGEL, DE
    WILSON, K
    OREILLY, S
    WILSON, J
    SUTTON, D
    PATER, J
    JOHNSTON, D
    ZEE, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) : 1397 - 1402
  • [6] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
    Berenson, JR
    Lichtenstein, A
    Porter, L
    Dimopoulos, MA
    Bordoni, R
    George, S
    Lipton, A
    Keller, A
    Ballester, O
    Kovacs, MJ
    Blacklock, HA
    Bell, R
    Simeone, J
    Reitsma, DJ
    Heffernan, M
    Seaman, J
    Knight, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) : 488 - 493
  • [7] CARLSON K, 1995, ACTA RADIOL, V36, P9
  • [8] MULTIPLE-MYELOMA - EFFECT OF DAILY DICHLOROMETHYLENE BISPHOSPHONATE ON SKELETAL COMPLICATIONS
    CLEMENS, MR
    FESSELE, K
    HEIM, ME
    [J]. ANNALS OF HEMATOLOGY, 1993, 66 (03) : 141 - 146
  • [9] THE USE OF CLODRONATE IN MULTIPLE-MYELOMA
    DELMAS, PD
    [J]. BONE, 1991, 12 : S31 - S34
  • [10] RELATION OF OSTEOCLAST ACTIVATING FACTOR PRODUCTION TO EXTENT OF BONE-DISEASE IN MULTIPLE-MYELOMA
    DURIE, BGM
    SALMON, SE
    MUNDY, GR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (01) : 21 - 30